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Abstract
Background: Several common genetic polymorphisms in the low density lipoprotein receptor (LDL-R) gene have
associated with modifications of serum total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) levels,
but the results are not consistent in different populations. Bai Ku Yao is a special subgroup of the Yao minority in
China. The present study was undertaken to detect the association of LDL-R gene Ava Ⅱ polymorphism and serum
lipid levels in the Guangxi Bai Ku Yao and Han populations.
Methods: A total of 1024 subjects of Bai Ku Yao and 792 participants of Han Chinese were randomly selected
from our previous stratified randomized cluster samples. Genotyping of the LDL-R gene Ava Ⅱ polymorphism was
performed by polymerase chain reaction and restriction fragment length polymorphism combined with gel
electrophoresis, and then confirmed by direct sequencing.
Results: The levels of serum TC, high density lipoprotein cholesterol (HDL-C), LDL-C, apolipoprotein (Apo) A1 and
the ratio of ApoA1 to ApoB were lower in Bai Ku Yao than in Han (P < 0.01 for all). The frequency of A
- and A
+
alleles was 65.5% and 34.5% in Bai Ku Yao, and 80.7% and 19.3% in Han (P < 0.001); respectively. The frequency of
A
-A
-,A
-A
+ and A
+A
+ genotypes was 42.6%, 45.9% and 11.5% in Bai Ku Yao, and 64.9%, 31.6% and 3.5% in Han (P <
0.001); respectively. There was also significant difference in the genotypic frequencies between males and females
in Bai Ku Yao (P <0.05), and in the genotypic and allelic frequencies between normal LDL-C (≤ 3.20 mmol/L) and
high LDL-C (>3.20 mmol/L) subgroups in Bai Ku Yao (P < 0.05 for each) and between males and females in Han (P
< 0.05 for each). The levels of LDL-C in males and TC and HDL-C in females were different among the three
genotypes (P < 0.05 for all) in Bai Ku Yao, whereas the levels of HDL-C in males and HDL-C and ApoA1 in females
were different among the three genotypes (P < 0.05-0.001) in Han. The subjects with A
+A
+ genotype had higher
serum LDL-C, TC, HDL-C or ApoA1 levels than the subjects with A
-A
+ and A
-A
- genotypes. Spearman rank
correlation analysis revealed that the levels of LDL-C in Bai Ku Yao and HDL-C in Han were correlated with
genotypes (P < 0.05 and P < 0.01; respectively).
Conclusions: The association of LDL-R gene Ava Ⅱ polymorphism and serum lipid levels is different between the
Bai Ku Yao and Han populations. The discrepancy might partly result from different LDL-R gene Ava Ⅱ
polymorphism or LDL-R gene-enviromental interactions.
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Dyslipidemia including high levels of plasma or serum
total cholesterol (TC) [1,2], triglycerides (TGs) [3,4], low
density lipoprotein cholesterol (LDL-C) [5,6] and apoli-
poprotein (Apo) B [7,8], and low levels of ApoA1 [7,8]
and high density lipoprotein cholesterol (HDL-C) [9,10],
is a growing healthcare problem and risk factor for com-
mon diseases such as atherosclerosis, coronary heart dis-
eases (CHD) and hypertension [11]. It has been
recognized that dyslipidemia is a multifactorial disease
involving environmental [12-14] and genetic factors
[15-21] and their interactions [22,23]. Family and twin
studies have shown that genetic polymorphisms could
account for 40-60% of the interindividual variation in
plasma lipid concentrations [24-26].
The low density lipoprotein receptor (LDL-R), a trans-
membrane cellular protein, plays a crucial role in the
receptor-mediated pathway of lipoprotein metabolism
[27,28]. The LDL-R modulates plasma levels of LDL-C
by regulating the uptake of LDL particles by the liver
and delivers cholesterol to the adrenal glands and
gonads for steroid hormone synthesis and to the liver
for bile acid synthesis [28,29]. Mutations in the LDL-R
gene that disturb the normal functions of the LDL-R
protein can cause familial hypercholesterolemia (FH),
which is associated with elevated total and LDL-C and
premature CHD [30,31]. FH, however, accounts for only
about 5% of patients with CHD, and the contribution of
genes to CHD in the remaining 95% of cases is still
unknown [32]. Common single nucleotide polymorph-
isms (SNPs) in genes involved in lipid metabolism are
potentially important genetic markers in affecting nor-
mal variation in the plasma or serum lipid profiles and
thus determining susceptibility or resistance to CHD in
the general population. Since the LDL-R gene plays an
important role in cholesterol homeostasis [28], it is also
possible that genetic variations in this gene may exist
that have only a small effect on the function of the
receptor. If such variations are common, they may make
an important contribution in determining plasma lipid
levels in the general population. The human LDL-R
gene consists of 18 exons and 17 introns with the length
of approximately 45 kb, and is mapped to chromosome
19p13.2. [33,34]. More than 12 restriction fragment
length polymorphisms (RFLPs) within and near the
LDL-R gene have been reported [35,36]. A common
Ava Ⅱ polymorphism has been found to be associate
with variation of plasma or serum lipid levels in some
studies [37-47] but not in others [48-50].
There are fifty-six ethnic groups in China. Han is the
largest group and Yao is the eleventh largest minority
among the 55 minority groups according to the popula-
tion size. Bai Ku Yao (White-trouser Yao), a special and
isolated subgroup of the Yao minority, is named so
because all the men wear white knee-length knicker-
bockers. The population size is about 30000. Because of
isolation from the other ethnic groups, the special cus-
toms and cultures including their clothing, intra-ethnic
marriages, dietary habits, and corn wine and rum
intakes are still completely preserved to the present day.
In several previous epidemiological studies, we found
that the serum lipid parameters were lower in Bai Ku
Yao than in Han Chinese from the same region [12-14].
This ethnic difference in serum lipid profiles is still not
well known. We postulated that there may be significant
differences in some lipid metabolism-related genetic
polymorphisms between the two ethnic groups. There-
fore, the aim of the present study was to detect the
association of LDL-R gene Ava Ⅱ polymorphism and
serum lipid levels in the Guangxi Bai Ku Yao and Han
populations.
Materials and methods
Study population
A total of 1024 subjects of Bai Ku Yao who reside in
Lihu and Baxu villages in Nandan County, Guangxi
Zhuang Autonomous Region, People’sR e p u b l i co f
China were randomly selected from our previous strati-
fied randomized cluster samples [12-14]. The ages of
the subjects ranged from 15 to 80 years, with an average
age of 36.01 ± 18.16 years. There were 468 males
(45.70%) and 556 females (54.30%). All subjects were
rural agricultural workers. The subjects accounted for
3.41% of total Bai Ku Yao population. During the same
period, a total of 792 people of Han Chinese who reside
in the same villages were also randomly selected from
our previous stratified randomized cluster samples
[12-14]. The mean age of the subjects was 35.67 ± 18.63
years (range 15 to 80). There were 330 men (41.67%)
and 462 women (58.33%). All of them were also rural
agricultural workers. All study subjects were essentially
healthy and had no evidence of any chronic illness,
including hepatic, renal, or thyroid. The participants
with a history of heart attack or myocardial infarction,
stroke, congestive heart failure, diabetes or fasting blood
glucose ≥ 7.0 mmol/L determined by glucose meter
have been excluded. The participants were not taking
medications known to affect serum lipid levels (lipid-
lowering drugs such as statins or fibrates, beta-blockers,
diuretics, or hormones). The present study was
approved by the Ethics Committee of the First Affiliated
Hospital, Guangxi Medical University. Informed consent
was obtained from all subjects after they received a full
explanation of the study.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods, following a common protocol [51].
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and lifestyle factors was collected with standardized
questionnaires. The alcohol information included ques-
t i o n sa b o u tt h en u m b e ro fl i a n g s( a b o u t5 0g )o fr i c e
wine, corn wine, rum, beer, or liquor consumed during
the preceding 12 months. Alcohol consumption was
categorized into groups of grams of alcohol per day: ≤
25 and ≥ 25. Smoking status was categorized into
groups of cigarettes per day: ≤ 20 and ≥ 20. At the phy-
sical examination, body height, weight, and waist cir-
cumference were measured. Sitting blood pressure was
measured three times with the use of a mercury sphyg-
momanometer after the subjects had a 5-minute rest,
and the average of the three measurements was used for
the level of blood pressure. Systolic blood pressure was
determined by the first Korotkoff sound, and diastolic
blood pressure by the fifth Korotkoff sound. Body
weight, to the nearest 50 grams, was measured using a
portable balance scale. Subjects were weighed without
shoes and in a minimum of clothing. Height was mea-
sured, to the nearest 0.5 cm, using a portable steel mea-
suring device. From these two measurements body mass
index (BMI, kg/m
2) was calculated. Waist circumference
was measured with a nonstretchable measuring tape, at
the level of the smallest area of the waist, to the nearest
0.1 cm.
Lipid analysis
A venous blood sample of 8 mL was obtained from all
subjects between 8 and 11 AM, after at least 12 hours
of fasting, from a forearm vein after venous occlusion
for few seconds in a sitting position. A part of the sam-
ple (3 mL) was collected into glass tubes and allowed to
clot at room temperature, and used to determine serum
lipid levels. Another part of the sample (5 mL) was
transferred to tubes with anticoagulate solution (4.80 g/
L citric acid, 14.70 g/L glucose, and 13.20 g/L tri-
sodium citrate) and used to extract DNA. Immediately
following clotting serum was separated by centrifugation
for 15 minutes at 3000 rpm. The levels of TC, TG,
HDL-C, and LDL-C in samples were determined by
enzymatic methods with commercially available kits,
Tcho-1, TG-LH (RANDOX Laboratories Ltd., Ardmore,
Diamond Road, Crumlin Co. Antrim, United Kingdom,
BT29 4QY), Cholestest N HDL, and Cholestest LDL
(Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan);
respectively. Serum ApoA1 and ApoB levels were
detected by the immunoturbidimetric immunoassay
using a commercial kit (RANDOX Laboratories Ltd.).
All determinations were performed with an autoanalyzer
(Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clinical
Science Experiment Center of the First Affiliated Hospi-
tal, Guangxi Medical University [12-14].
DNA amplification and genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using the phenol-chloroform method [15-21].
The extracted DNA was stored at 4°C until analysis.
Genotyping of the LDL-R gene Ava Ⅱ polymorphism
was performed by polymerase chain reaction and restric-
tion fragment length polymorphism (PCR-RFLP) [32,48].
PCR amplification was carried out with forward primer
5’-GTCATCTTCCTTGCTGCCTGTTTAG-3’ and
reverse primer 5’-GTTTCCACAAGGAGGTTT-
CAAGGTT-3’ (Sangon, Shanghai, People’s Republic of
China). Each amplification reaction was performed in a
total volume of 25 mL, containing 3 μLo fg e n o m i c
DNA, 1.0 μL of each primer (10 μmol/L), 7.5 μLo f
ddH2O, and 12.5 μL2×Taq PCR MasterMix (constitu-
ent: 0.1 U Taq polymerase/μL, 500 μM dNTP each and
PCR buffer). After initial denaturizing at 94°C for 3 min,
the reaction mixture was subjected to 30 cycles of 30 s
denaturation at 94°C, 30 s annealing at 55°C and exten-
sion 60 s at 72°C, followed by a final 5 min extension at
72°C. After electrophoresis on a 2.5% agarose gel with
0.5 μg/mL ethidium bromide, the amplification products
were visualized under ultraviolet light. Then 10 U of
Ava Ⅱ enzyme was added directly to the PCR products
(8 μL )a n dd i g e s t e da t3 7 ° Co v e r n i g h t .A f t e rr e s t r i c t i o n
enzyme digestion of the amplified DNA, the genotypes
were identified by electrophoresis on 2.5% agarose gels
and visualized with ethidium-bromide staining ultravio-
let illumination. The genotypes were scored by an
experienced reader blinded to epidemiological data and
serum lipid levels. Six samples (A
-A
-,A
-A
+ and A
+A
+
genotypes in two; respectively) detected by the PCR-
RFLP were also confirmed by direct sequencing. The
PCR products were purified by low melting point gel
electrophoresis and phenol extraction, and then the
DNA sequences were analyzed in Shanghai Sangon Bio-
logical Engineering Technology & Services Co., Ltd.,
People’s Republic of China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoA1, ApoB levels, and the ratio of ApoA1 to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78, 0.63-
1.14 g/L, and 1.00-2.50; respectively. The individuals with
TC >5.17 mmol/L and/or TG >1.70 mmol/L were
defined as hyperlipidemic [12-14]. Hypertension was
diagnosed according to the criteria of 1999 World Health
Organization-International Society of Hypertension
Guidelines for the management of hypertension [52,53].
T h ed i a g n o s t i cc r i t e r i ao fo verweight and obesity were
according to the Cooperative Meta-analysis Group of
China Obesity Task Force. Normal weight, overweight
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kg/m
2; respectively [54].
Statistical analyses
Epidemiological data were recorded on a pre-designed
form and managed with Excel software. All statistical
analyses were done with the statistical software package
SPSS 13.0 (SPSS Inc., Chicago, Illinois). Quantitative
variables were expressed as mean ± standard deviation
(SD), and qualitative variables as percentages. Allele fre-
quency was determined via direct counting, and the
standard goodness-of-fit test was used to test the
Hardy-Weinberg equilibrium. Differences in genotype
distribution between the groups were obtained using the
chi-square test. The difference in general characteristics
between Bai Ku Yao and Han was tested by the Stu-
dent’su n p a i r e dt-test. The association of serum lipid
variables with genotypes was tested by analysis of covar-
iance (ANCOVA). Sex, age, BMI, blood pressure, alco-
hol intake, cigarette smoking were adjusted for the
statistical analysis. In order to confirm the association of
serum lipid parameters and genotypes (A
-A
- =1 ,A
-A
+
=2a n dA
+A
+ = 3), Spearman rank correlation analysis
was also performed in the combined population of Bai
Ku Yao and Han, Bai Ku Yao, and Han; respectively. A
P value of less than 0.05 was considered statistically
significant.
Results
General characteristics and serum lipid levels
Table 1 gives the general characteristics and serum lipid
levels between the Bai Ku Yao and Han populations.
The levels of body height, weight, TC, HDL-C, LDL-C,
ApoA1 and the ratio of ApoA1 to ApoB were lower in
Bai Ku Yao than in Han (P < 0.01 for all), whereas the
percentages of subjects who consumed alcohol or
smoked cigarettes were higher in Bai Ku Yao than in
Han (P < 0.01 for each). There was no significant differ-
ence in the levels of BMI, systolic blood pressure, dia-
stolic blood pressure, pulse pressure, TG, ApoB, age
structure, and the ratio of male to female between the
two ethnic groups (P >0.05 for all).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified by
PCR and imaged by 2.5% agarose gel electrophoresis, the
PCR products of 228 bp nucleotide sequences could be
found in all samples (Figure 1). The genotypes identified
Table 1 The general characteristics and serum lipid levels between the Bai Ku Yao and Han populations
Parameter Bai Ku Yao Han Chinese t (x
2) P
Number 1024 792 - -
Male/female 468/556 330/462 2.954 0.085
Age (years) 36.01 ± 18.16 35.67 ± 18.63 0.275 0.783
Height (cm) 151.84 ± 7.13 156.30 ± 7.82 -12.670 0.000
Weight (kg) 49.98 ± 7.19 53.26 ± 10.30 -7.982 0.000
Body mass index (kg/m
2) 21.64 ± 2.47 21.75 ± 3.64 -0.766 0.444
Waist circumference (cm) 70.80 ± 7.76 71.09 ± 10.27 -0.486 0.627
Systolic blood pressure (mmHg) 116.94 ± 16.68 117.36 ± 17.36 -0.361 0.718
Diastolic blood pressure (mmHg) 74.06 ± 9.41 73.77 ± 10.57 0.444 0.657
Pulse pressure (mmHg) 42.89 ± 12.09 43.59 ± 11.89 -0.878 0.380
Cigarette smoking [n (%)]
Nonsmoker 786 (76.8) 636 (80.3)
<20 cigarettes/day 120 (11.7) 58 (7.3)
≥ 20 cigarettes/day 118 (11.5) 98 (12.4) 9.791 0.007
Alcohol consumption [n (%)]
Nondrinker 688 (67.2) 646 (81.6)
<25 g/day 216 (21.1) 106 (13.4)
≥ 25 g/day 120 (11.7) 40 (5.1) 50.079 0.000
Total cholesterol (mmol/L) 4.21 ± 0.96 4.51 ± 0.99 -4.624 0.000
Triglyceride (mmol/L) 1.23 ± 0.80 1.25 ± 0.91 -0.358 0.721
HDL-C (mmol/L) 1.58 ± 0.42 1.74 ± 0.49 -5.350 0.000
LDL-C (mmol/L) 2.48 ± 0.74 2.63 ± 0.79 -2.991 0.003
Apolipoprotein (apo) AI (g/L) 1.24 ± 0.32 1.34 ± 0.36 -4.708 0.000
ApoB (g/L) 0.81 ± 0.24 0.79 ± 0.21 1.562 0.119
ApoAI/ApoB 1.63 ± 0.65 1.78 ± 0.60 -3.561 0.000
HDL-C, highdensity lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol
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enzyme restriction sites. The presence of the cutting site
indicates the A
+ allele, while its absence indicates the A
-
allele (cannot be cut). Thus, A
+A
+ genotypes were
homozygotes for the presence of the site (141- and 87-
bp), A
-A
+ genotypes were heterozygotes for the absence
and presence of the site (228-, 141- and 87-bp), and A
-
A
- genotypes were homozygotes for the absence of the
site (228-bp; Figure 2); respectively. The genotypic dis-
tribution was consistent with the Hardy-Weinberg
equilibrium.
Genotypic and allelic frequencies
The genotypic and allelic frequencies of LDL-R gene Ava Ⅱ
polymorphism in Bai Ku Yao and Han Chinese are shown
in Table 2. The frequency of A
- and A
+ alleles was 65.5%
and 34.5% in Bai Ku Yao, and 80.7% and 19.3% in Han (P <
0.001); respectively. The frequency of A
-A
-,A
-A
+ and A
+A
+
genotypes was 42.6%, 45.9% and 11.5% in Bai Ku Yao, and
64.9%, 31.6% and 3.5% in Han (P < 0.001); respectively.
There was also significant difference in the genotypic fre-
quencies between males and females (P < 0.05) and in the
genotypic and allelic frequencies between normal LDL-C (≤
3.20 mmol/L) and high LDL-C (>3.20 mmol/L; P < 0.05 for
each) subgroups in Bai Ku Yao, and in the genotypic
and allelic frequencies between males and females in Han
(P < 0.05 for each).
Results of sequencing
The results were shown as A
-A
-,A
-A
+ and A
+A
+ geno-
types by PCR-RFLP, the A
-A
-,A
-A
+ and A
+A
+ geno-
types were also confirmed by sequencing (Figure 3);
respectively.
Genotypes and serum lipid levels
As shown in Table 3, the levels of TC and LDL-C in Bai
Ku Yao were significant differences among the three
genotypes (P < 0.05 and P < 0.01; respectively). The sub-
jects with A
+A
+ genotype had higher serum TC levels
than the subjects with A
-A
+ genotypes, and higher
serum LDL-C levels than the subjects with A
-A
+ and A
-
A
- genotypes. When the associations of genotypes and
serum lipid parameters were analyzed according to sex,
the levels of LDL-C in males and TC and HDL-C in
females were significant differences among the three
genotypes (P < 0.05 for all). The subjects with A
+A
+
Figure 1 Electrophoresis of PCR products of the samples. Lane M, 50 bp marker ladder; lanes 1-10, samples. The 228 bp bands are the PCR
products.
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than the subjects with A
-A
+ and A
-A
- genotypes.
The levels of HDL-C in Han Chinese were significant
differences among the three genotypes (P < 0.001). The
subjects with A
+A
+ genotype had higher serum HDL-C
levels than the subjects with A
-A
+ and A
-A
- genotypes.
When the assocoations of genotypes and serum lipid
parameters were analyzed according to sex, the levels of
HDL-C in males and HDL-C and ApoA1 in females
were significant differences among the three genotypes
(P < 0.05-0.001). The subjects with A
+A
+ genotype had
higher serum HDL-C and ApoA1 levels than the sub-
jects with A
-A
+ and A
-A
- genotypes.
Risk factors for the lipid parameters
Spearman rank correlation analysis showed that serum
LDL-C levels in Bai Ku Yao were correlated with geno-
types (P < 0.05), whereas serum HDL-C levels in Han
Chinese were associated with genotypes (P < 0.01; Table
4).
Discussion
T h ep r e s e n ts t u d ys h o w e dt h a tt h el e v e l so fs e r u mT C ,
HDL-C, LDL-C, ApoA1 and the ratio of ApoA1 to
ApoB were lower in Bai Ku Yao than in Han. There was
no significant difference in serum TG and ApoB levels
between the two ethnic groups. These findings are con-
sistent with those of our previous epidemiological stu-
dies [12-14]. It is well known that dyslipidemia is a
complex trait caused by multiple environmental and
genetic factors and their interactions. Differences in
serum lipid profiles between the two ethnic groups
might mainly result from different dietary patterns, life-
style factors as well as genetic background. Bai Ku Yao
is an isolated subgroup of the Yao minority in China.
There are about 30000 people of total Bai Ku Yao popu-
lation who reside in two villages, Lihu and Baxu, Nan-
dan County. Their ancestors began their migration from
Hunan and Guizhou Province about Song Dynasty (a
ruling dynasty in China between 960 and 1279). Both
Lihu and Baxu villages are typical infertile mountain
area, usually it was called 30 percent soil with 70 per-
cent rock. Their income mostly comes from planting
corn and paddy. Thus, corn was the staple food and
rice, soy, buckwheat, sweet potato, and pumpkin pro-
ducts were the subsidiary foods in Bai Ku Yao. Approxi-
mately 90% of the beverages were corn wine and rum.
The alcohol content is about 15% (v/v). They are also
accustomed to drink hempseed soup and eat hempseed
products. Several experimental and clinical studies have
demonstrated that the Hempseed products and Hemp-
seed oil can decrease serum TC, TG and LDL-C levels
[55-57]. In contrast, rice was the staple food and corn,
broomcorn, potato, and taro products were the subsidi-
ary foods in Han. About 90% of the beverage was rice
wine. The content of alcohol is about 30% (v/v). The
staple and subsidiary foods are more favorable for
serum lipid profiles in Bai Ku Yao than in Han [58-62].
Figure 2 Genotyping of the LDL-R gene Ava Ⅱ polymorphism.L a n eM ,5 0b pm a r k e rl a d d e r ;l a n e s1 - 6 ,A
+A
+ genotype (141- and 87-bp);
lanes 7-12, A
-A
+ genotype (228-, 141- and 87-bp); and lanes 13-15, A
-A
- genotype (228-bp).
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formed in this ethnic subgroup from time immemorial.
Namely, only both Bai Ku Yao man and woman can
intermarriage, and can not intermarry with the other
subgroup of Yao minority or other ethnic groups.
Therefore, this unique ethnic subgroup with a homoge-
nous environmental and genetic background is a useful
tool for genetic study.
Several previous studies have shown that the genoty-
pic and allelic distribution of LDL-R gene Ava Ⅱ poly-
morphism was different in diverse populations. Ahn et
al. [32] investigated the effect of LDL-R gene Ava Ⅱ
polymorphism on plasma lipid profiles in 385 normoli-
pidemic Hispanics and 543 non-Hispanic whites from
the San Luis Valley, Colorado. They showed that the
frequency of A
+ allele was higher in Hispanics than in
non-Hispanic whites (56% vs. 43%; P< 0.001). Salazar et
al. [38] reported that the frequency of A
+A
+ genotype
was higher in 170 white unrelated individuals presenting
a lipid profile with high risk for CHD compared to that
of the 130 controls (32% vs. 16%) from São Paulo City,
Brazil. Salazar et al. [40] also found that the frequency
of A
+ allele was higher in 50 patients with FH than in
130 normal controls (58% vs. 45%; P = 0.036). The FH
patients showed a greater frequency of A
+A
+ homozy-
gous genotypes when compared to the normolipidemic
controls (P = 0.0292). In addtion, several studies also
showed that the frequency of A
+ allele was higher in
patients with acute myocardial infarction [45], phlegm-
dampness constitution [47], gallstone disease [48], but
was lower in patients with atherosclerotic cerebral
infarction [50] as compared with the corresponding
Table 2 Comparison of the genotypic and allelic frequencies of LDL-R gene Ava Ⅱ polymorphism in Bai Ku Yao and
Han Chinese [n (%)]
Group n Genotype Allele
A
-A
- A
-A
+ A
+A
+ A
- A
+
Bai Ku Yao 1024 436 (42.6) 470 (45.9) 118 (11.5) 1342 (65.5) 706 (34.5)
Han Chinese 792 514 (64.9) 250 (31.6) 28 (3.5) 1278 (80.7) 306 (19.3)
x
2 - 101.118 102.054
P - 0.000 0.000
Bai Ku Yao
Male 468 218(46.6) 190(40.6) 60(12.8) 626(66.9) 310(33.1)
Female 556 220(39.6) 278(50.0) 58(10.4) 718(64.6) 394(35.4)
x
2 - 9.095 1.204
P - 0.011 0.272
Normal TC 882 368 (41.7) 420 (47.6) 94 (10.7) 1156 (65.5) 608 (34.5)
High TC 142 68 (47.9) 50 (35.2) 24 (16.9) 186 (65.5) 98 (34.5)
x
2 - 9.332 0.000
P - 0.009 0.990
Normal LDL-C 902 392 (43.5) 414 (45.9) 96 (10.6) 1198 (66.4) 606 (33.6)
High LDL-C 122 44 (36.1) 56 (45.9) 22 (18.0) 144 (59.0) 100 (41.0)
x
2 - 6.472 5.199
P - 0.039 0.023
Han Chinese
Male 330 230 (69.7) 92 (27.9) 8 (2.4) 552 (83.6) 108 (16.4)
Female 462 284 (61.5) 158 (34.2) 20 (4.3) 726 (78.6) 198 (21.4)
x
2 - 6.418 6.337
P - 0.040 0.012
Normal TC 622 412 (66.2) 190 (30.6) 20 (3.2) 1014 (81.5) 230 (18.5)
High TC 170 102 (60.0) 60 (35.3) 8 (4.7) 264 (77.6) 76 (22.4)
x
2 - 2.593 2.558
P - 0.274 0.109
Normal LDL-C 636 414 (65.1) 202 (31.8) 20 (3.1) 1030 (81.0) 242 (19.0)
High LDL-C 156 100 (64.1) 48 (30.8) 8 (5.1) 248 (79.5) 64 (20.5)
x
2 - 1.452 0.356
P - 0.484 0.550
TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; Normal TC, TC ≤ 5.17 mmol/L, High TC, TC >5.17 mmol/L; Normal LDL-C, LDL-C ≤ 3.20 mmol/L,
High LDL-C, LDL-C >3.20 mmol/L
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Page 7 of 12normal controls; respectively. Liu et al. [43] found that
the frequency of A
+ allele in males but not in females
was higher in hyperlipidemic (24.51%) and margin lipid
patients (25.00%) than in normal controls (11.11%; P <
0.05 for each). Several studies, however, showed that
there was no significant difference in the frequency of A
+ allele between the CHD and control groups [44,46],
and between male and female Han children [49]. In the
present study, we showed that the frequency of A
+ allele
and A
-A
+ and A
+A
+ genotypes was higher in Bai Ku
Yao than in Han. There was also significant difference
in the genotypic frequencies between males and females
in Bai Ku Yao, and in the genotypic and allelic frequen-
cies between normal LDL-C (≤ 3.20 mmol/L) and high
LDL-C (>3.20 mmol/L) subgroups in Bai Ku Yao and
between males and females in Han. These results indi-
cate that the prevalence of the A
+ allele variants of
LDL-R gene Ava Ⅱ polymorphism may have a racial/eth-
nic specificity.
The association of LDL-R gene Ava Ⅱ polymorphism
and plasma or serum lipid levels in humans are
inconsistent in several previous studies. Ahn et al. [32]
reported that the LDL-R gene Ava Ⅱ polymorphism
revealed a gender-specific effect on plasma lipid profiles.
The gender-specific effect was significant for HDL-C (P
< 0.001) and TG (P = 0.001). Ethnicity affected only the
levels of TG (P = 0.02). Significant variability among
Ava II genotypes was observed for TC and LDL-C in
non-Hispanic women (P = 0.0015 and P =0 . 0 1 4 )a n d
TC in Hispanic women (P = 0.011) and was highly sug-
gestive for LDL-C in Hispanic women (P = 0.057). For
both non-Hispanic and Hispanic women the trends seen
in the cholesterol levels were similar: low in the A
-A
-
genotype, intermediate in the A
-A
+ genotype, and high
in the A
+A
+ genotype. Neither significant nor directional
results were seen in men in either ethnic group. In non-
Hispanic women the estimated average effect of the A
+
allele was to raise LDL-C by 4.95 mg/dL, and the aver-
age effect of the A
- allele was to lower LDL-C by 3.68
mg/dL; this variation explained 3.9% of the phenotypic
variance in TC and 2.3% in LDL-C. In Hispanic women
the estimated average effect of the A
+ allele was to
Figure 3 A part of the nucleotide sequence of LDL-R gene Ava Ⅱ polymorphism. (A) A
-A
- genotype; (B) A
-A
+ genotype; (C) A
+A
+ genotype.
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Page 8 of 12increase LDL-C by 2.92 mg/dL, and the A
- allele low-
ered levels by 3.81 mg/dL; this variation explained 3.7%
and 2% of the phenotypic variance in TC and LDL-C;
respectively. Humphries et al. [37] showed that the indi-
viduals with one or two A
- alleles (absence of cutting
site) had levels of LDL-C that were lower by 8.0% and
12.4%; respectively. Variation associated with this RFLP
explained 4.2% of the sample variance. Pongrapeeporn
et al. [41] also revealed that the mean LDL-C levels was
slightly higher in the A
+A
+ genotype than the A
-A
+ and
A
-A
- genotypes in 54 normolipidemic Thai subjects.
The difference was significant at the 5 per cent level
although there were only three homozygotes with the A
+A
+ genotype. The average effect of the A
+ allele was to
increase LDL-C level by 6.75 mg/dl. A gene-dosage
effect was not observed for this polymorphism. In addi-
tion, the subjects with the A
+A
+ genotype also tended
to have high serum TC and TG and low HDL-C levels.
The LDL-R gene Ava Ⅱ polymorphism was also found
to be associate with the variability of plasma or serum
lipid levels in subjects presenting a lipid profile with
high risk for CHD [38], in normal individuals from five
Table 3 Comparison of serum lipid levels among the genotypes of LDL-R gene Ava Ⅱ polymorphism in Bai Ku Yao and
Han Chinese
Genotype n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L) ApoAI (g/L) ApoB (g/L)
Bai Ku Yao
A
-A
- 436 4.23 ± 0.98 1.26 ± 0.82 1.58 ± 0.42 2.44 ± 0.69 1.24 ± 0.33 0.82 ± 0.23
A
-A
+ 470 4.14 ± 0.81 1.19 ± 0.79 1.56 ± 0.40 2.45 ± 0.65 1.22 ± 0.31 0.81 ± 0.24
A
+A
+ 118 4.38 ± 0.86
c 1.27 ± 0.73 1.66 ± 0.49 2.71 ± 1.12
bd 1.28 ± 0.33 0.86 ± 0.24
F - 3.673 1.050 2.676 6.792 1.724 2.122
P - 0.026 0.350 0.069 0.001 0.179 0.120
Male
A
-A
- 218 4.17 ± 1.16 1.36 ± 1.00 1.57 ± 0.45 2.34 ± 0.80 1.25 ± 0.38 0.75 ± 0.27
A
-A
+ 190 4.05 ± 0.90 1.28 ± 1.00 1.56 ± 0.50 2.32 ± 0.70 1.23 ± 0.40 0.75 ± 0.23
A
+A
+ 60 4.23 ± 0.86 1.30 ± 0.79 1.62 ± 0.53 2.69 ± 1.45
bc 1.27 ± 0.36 0.82 ± 0.29
F - 1.030 0.355 0.359 4.443 0.287 1.936
P - 0.358 0.123 0.699 0.012 0.751 0.146
Female
A
-A
- 220 4.28 ± 0.77 1.17 ± 0.58 1.59 ± 0.38 2.55 ± 0.53 1.23 ± 0.28 0.86 ± 0.18
A
-A
+ 278 4.20 ± 0.75 1.13 ± 0.62 1.56 ± 0.31 2.53 ± 0.60 1.21 ± 0.23 0.85 ± 0.23
A
+A
+ 58 4.53 ± 0.84
ad 1.23 ± 0.69 1.70 ± 0.45
ac 2.73 ± 0.64 1.30 ± 0.31 0.90 ± 0.17
F - 4.494 0.732 3.746 2.917 2.901 1.420
P - 0.012 0.482 0.024 0.055 0.056 0.243
Han Chinese
A
-A
- 514 4.49 ± 1.02 1.23 ± 0.87 1.70 ± 0.47 2.63 ± 0.82 1.34 ± 0.34 0.79 ± 0.21
A
-A
+ 250 4.56 ± 0.94 1.31 ± 0.99 1.78 ± 0.50 2.63 ± 0.76 1.35 ± 0.38 0.79 ± 0.20
A
+A
+ 28 4.44 ± 1.08 1.17 ± 1.08 2.14 ± 0.54
bd 2.60 ± 0.77 1.40 ± 0.45 0.79 ± 0.23
F - 0.486 0.759 12.262 0.018 0.407 0.004
P - 0.615 0.469 0.000 0.982 0.666 0.996
Male
A
-A
- 230 4.45 ± 0.94 1.35 ± 1.13 1.62 ± 0.48 2.64 ± 0.75 1.30 ± 0.37 0.80 ± 0.21
A
-A
+ 92 4.45 ± 0.93 1.50 ± 1.28 1.73 ± 0.44 2.54 ± 0.82 1.33 ± 0.39 0.76 ± 0.20
A
+A
+ 8 3.80 ± 1.45 1.56 ± 1.78 1.77 ± 0.46 2.17 ± 0.92 1.02 ± 0.21 0.66 ± 0.21
F - 1.823 0.598 2.059 1.818 2.549 2.725
P - 0.163 0.550 0.129 0.164 0.080 0.067
Female
A
-A
- 284 4.53 ± 1.09 1.13 ± 0.56 1.76 ± 0.45 2.62 ± 0.87 1.36 ± 0.32 0.78 ± 0.22
A
-A
+ 158 4.62 ± 0.95 1.20 ± 0.76 1.82 ± 0.54 2.69 ± 0.72 1.37 ± 0.38 0.81 ± 0.20
A
+A
+ 20 4.79 ± 0.66 0.95 ± 0.38 2.35 ± 0.49 2.83 ± 0.61 1.56 ± 0.42
ac 0.87 ± 0.70
F - 0.857 1.640 13.965 0.874 3.123 1.658
P - 0.425 0.195 0.000 0.418 0.045 0.192
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B;
aP < 0.05 and
bP < 0.01 in comparison with A
-A
- genotype of same group;
cP < 0.05 and
dP < 0.01 in comparison with A
-A
+ genotype of same
group.
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Page 9 of 12Brazilian Indian tribes [39], in males with hypercholes-
terolemia [43], in cases with acute myocardial infarction
[45], in patients with CHD [46], and in population with
phlegm-dampness constitution [47]. Several studies,
however, failed to find a significant association between
the LDL-R gene Ava Ⅱ polymorphism and plasma or
serum lipid levels in normal controls [48,50] or in Han
children [49]. In the present study, we showed that the
levels of TC and LDL-C in Bai Ku Yao were significant
differences among the three genotypes. The subjects
with A
+A
+ genotype had higher serum TC levels than
the subjects with A
-A
+ genotypes, and higher serum
LDL-C levels than the subjects with A
-A
+ and A
-A
- gen-
otypes. When the statistical analyses were performed
according to sex, the levels of LDL-C in males and TC
and HDL-C in females were significant differences
among the three genotypes. The subjects with A
+A
+
genotype had higher serum LDL-C, TC or HDL-C levels
than the subjects with A
-A
+ and A
-A
- genotypes. The
levels of HDL-C in Han Chinese were significant differ-
ences among the three genotypes. The subjects with A
+A
+ genotype had higher serum HDL-C levels than the
subjects with A
-A
+ and A
-A
- genotypes. When the ana-
lyses were performed for each gender category sepa-
rately, the levels of HDL-C in males and HDL-C and
ApoA1 in females were significant differences among
the three genotypes. The subjects with A
+A
+ genotype
had higher serum HDL-C and ApoA1 levels than the
subjects with A
-A
+ and A
-A
- genotypes. Spearman rank
correlation analysis showed that serum LDL-C levels in
Bai Ku Yao were correlated with genotypes, whereas
serum HDL-C levels in Han Chinese were associated
with genotypes. The reason for this discrepancy between
the two ethnic groups may relate to the difference in
the LDL-R gene Ava Ⅱ polymorphism and/or LDL-R
gene-enviromental interactions [44].
Conclusion
The present study shows that the frequency of A
+ allele
and A
-A
+ and A
+A
+ genotypes was higher in Bai Ku
Yao than in Han. There was also significant difference
in the genotypic frequencies between males and females
and in the genotypic and allelic frequencies between
normal LDL-C (≤ 3.20 mmol/L) and high LDL-C (>3.20
mmol/L) subgroups in Bai Ku Yao, and in the genotypic
and allelic frequencies between males and females in
Han. The levels of LDL-C in males and TC and HDL-C
in females were different among the three genotypes in
Bai Ku Yao, whereas the levels of HDL-C in males and
HDL-C and ApoA1 in females were different among the
three genotypes in Han. The A
+A
+ homozygotes had
higher serum LDL-C, TC, HDL-C or ApoA1 levels than
the A
-A
+ heterozygotes and A
-A
- homozygotes. The
levels of LDL-C in Bai Ku Yao and HDL-C in Han were
correlated with genotypes. The difference in the associa-
tion of LDL-R gene Ava Ⅱ polymorphism and serum
lipid levels between the two ethnic groups might partly
result from different LDL-R gene Ava Ⅱ polymorphism
or LDL-R gene-enviromental interactions.
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